(Q39616383)

English

1,25-dihydroxyvitamin D3 and a superagonistic analog in combination with paclitaxel or suberoylanilide hydroxamic acid have potent antiproliferative effects on anaplastic thyroid cancer

scientific article published on 21 December 2010

Statements

1,25-dihydroxyvitamin D3 and a superagonistic analog in combination with paclitaxel or suberoylanilide hydroxamic acid have potent antiproliferative effects on anaplastic thyroid cancer (English)
Isabelle Clinckspoor
Lieve Verlinden
Lutgart Overbergh
Christopher Korch
Annemieke Verstuyf
Brigitte Decallonne
21 December 2010
1-2

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit